McKesson Debt to Equity Ratio 2006-2018 | MCK

Current and historical debt to equity ratio values for McKesson (MCK) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $208.357B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.026B 24.73
Align Technology (ALGN) United States $29.131B 86.13
AmerisourceBergen (ABC) United States $19.323B 14.07
Laboratory Of America Holdings (LH) United States $19.077B 18.43
Cardinal Health (CAH) United States $15.783B 9.96
Cooper (COO) United States $12.135B 22.59
Henry Schein (HSIC) United States $11.530B 20.43
DENTSPLY SIRONA (XRAY) United States $10.314B 17.31
West Pharmaceutical Services (WST) United States $7.360B 41.00
Merit Medical Systems (MMSI) United States $2.811B 42.23
Halyard Health (AVNS) United States $2.765B 22.62
Patterson (PDCO) United States $2.171B 13.64
CONMED (CNMD) United States $2.069B 35.99
STAAR Surgical (STAA) United States $1.351B 463.57
Atrion (ATRI) United States $1.143B 32.63
Invacare (IVC) United States $0.684B 0.00
Endologix (ELGX) United States $0.462B 0.00
Antares Pharma (ATRS) United States $0.422B 0.00
Lifevantage (LFVN) United States $0.133B 27.47
Aceto (ACET) United States $0.105B 4.28
Pro-Dex (PDEX) United States $0.029B 12.77
Milestone Scientific (MLSS) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.027B 0.00
Biolase (BIOL) United States $0.027B 0.00